| Ʈ ǻ簡 м Ʈ ٽ 븸 Ӻ մϴ. ǰ, ǥ, Ʈ ֿ , ֱ ˷ 帳ϴ.
15 Ʈコɾ ǰ ż, ǥ 86000 ߴ. ̹ ǥ ǥ 11 21% ߴ.籸 ۼ Ʈコɾ Ʈ ֿ䳻 Ʒ .
Ʈø 긶 ̱ Ǹ Ұ Ȯ ̿ùз 忡 ü ǴϿ ǰ BUY . ø/÷Ʈ: (1) 54% ̸ Ǹ Floor price Ͽ ߰ ϶ Ǵ. (2) 19 4Q SC 밡. (3) Ϲ 10% 19 15%Ʈø: (1) 32% · 굵 7% ٰ Ǵ. (2) Ϲ 12 ǸŽ ϸ 19 . Ʈʻ Teva ĥ . 굵 Ϲ̽ ϸ ٳⰣ ̿ùз 峻 Ǵ. 19 ͷ . ٸ ν ǰ Teva ǰ νĵǾ 6 lagging . 긶: (1) 2 б⸸ 7% ر ö · ۳ Ʈ Ǵ. (2) Ϲ Ư ȣ 19 6 Ǿ 12 Ad-Risk . First-mover ħ ȭ . ַǰ 簡ġ ͷ (16 17 ġ 18%) ͷ 12% ϸ ǥְ .
14 ְ ϴ 3.30% 62600 ߴ. ְ(PER) 57.4, ְڻ(PBR) 4.92, ڱںͷ(ROE) 8.6%.
[ٷΰ] ǻ 'Ʈ'
http://www.wisereport.co.kr/
( 0)